Hip resurfacing devices have only become available in the U.S. in the last two years (Smith & Nephew introduced the BHR in 2006 and Stryker began distributing Corin's Cormet in 2007), and with the relatively recent launch comes an "incomplete"... more
Mesoblast announced positive results from an Australian study evaluating the use of its proprietary stem cell therapy in the treatment of non-healing long bone fractures. 10 patients with 11 fractures were enrolled in the study and received the stem cell... more
CMS released a list last week of 19 potential topics for National Coverage Decisions. These topics include a number of orthopedic devices: Artificial cervical discs Bone morphogenetic protein Hip resurfacing Vertebroplasty and kyphoplasty Lumbar fusion for degenerative disc disease As... more
Dr. Gary Michelson knows his patent rights.
Medtronic made him a billionaire for it.
Knowing the rules of intellectual property is just as important for any device firm.
It's such a critical factor in firm valuations: affecting cash flow timelines, product development, partnering, and many other competitive factors.
Purchase this report for $295 »
